Literature DB >> 18850458

Transgenic mice expressing cyan fluorescent protein as a reporter strain to detect the effects of rotenone toxicity on retinal ganglion cells.

C R Hayworth1, J C Rojas, F Gonzalez-Lima.   

Abstract

This is the first study using a reporter transgenic model to investigate the effects of an environmental toxin on the retina. Rotenone is a widely used pesticide that inhibits mitochondrial complex I and produces neurotoxicity. Previous studies demonstrated the time course and dose response of rotenone toxicity on retinal ganglion cells (RGC). However, previous analyses of rotenone-induced retinotoxicity provided little detail of the optic nerve axons and cellular pathology. These limitations were successfully surmounted by using a transgenic mouse line shown to express cyan fluorescent protein (CFP) in neurons, including RGC, under regulatory elements of the human the thy1.1 promoter (thy-CFP). Data showed that CFP expression is limited to RGC and their processes in the retina of thy-CFP mice. Eyes exposed to the pesticide rotenone displayed marked alterations in RGC morphology, inner plexiform layer, optic disc, and optic nerves. After 24 h, the number of CFP-labeled RGC was reduced 50%. Correlated with a loss of RGC bodies was an approximate 50% reduction in CFP fluorescence intensity at the optic disc. The findings showed that rotenone-induced degeneration of RGC and their processes can be visualized with exquisite detail in thy-CFP mice, and that this approach may provide a novel and effective way to monitor the association between environmental toxins and neurodegeneration in living animals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18850458     DOI: 10.1080/15287390802414190

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  7 in total

Review 1.  Mitochondrial optic neuropathy: In vivo model of neurodegeneration and neuroprotective strategies.

Authors:  Julio C Rojas; Francisco Gonzalez-Lima
Journal:  Eye Brain       Date:  2010-03-10

2.  Cell therapy using retinal progenitor cells shows therapeutic effect in a chemically-induced rotenone mouse model of Leber hereditary optic neuropathy.

Authors:  Fiona C Mansergh; Naomi Chadderton; Paul F Kenna; Oliviero L Gobbo; G Jane Farrar
Journal:  Eur J Hum Genet       Date:  2014-02-26       Impact factor: 4.246

3.  A rapid fluorescent method to quantify neuronal loss after experimental intracerebral hemorrhage.

Authors:  Jing Chen-Roetling; Xiangping Lu; Kathleen A Regan; Raymond F Regan
Journal:  J Neurosci Methods       Date:  2013-04-10       Impact factor: 2.390

4.  Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy.

Authors:  Fabrice D Heitz; Michael Erb; Corinne Anklin; Dimitri Robay; Vincent Pernet; Nuri Gueven
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

5.  Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy.

Authors:  Naomi Chadderton; Arpad Palfi; Sophia Millington-Ward; Oliverio Gobbo; Nora Overlack; Matthew Carrigan; Mary O'Reilly; Matthew Campbell; Carsten Ehrhardt; Uwe Wolfrum; Peter Humphries; Paul F Kenna; G Jane Farrar
Journal:  Eur J Hum Genet       Date:  2012-06-06       Impact factor: 4.246

6.  A single intravenous AAV9 injection mediates bilateral gene transfer to the adult mouse retina.

Authors:  Alexis-Pierre Bemelmans; Sandra Duqué; Christel Rivière; Stéphanie Astord; Mélissa Desrosiers; Thibault Marais; José-Alain Sahel; Thomas Voit; Martine Barkats
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

7.  Visual properties of transgenic rats harboring the channelrhodopsin-2 gene regulated by the thy-1.2 promoter.

Authors:  Hiroshi Tomita; Eriko Sugano; Yugo Fukazawa; Hitomi Isago; Yuka Sugiyama; Teru Hiroi; Toru Ishizuka; Hajime Mushiake; Megumi Kato; Masumi Hirabayashi; Ryuichi Shigemoto; Hiromu Yawo; Makoto Tamai
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.